{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:42:29Z","timestamp":1782978149181,"version":"3.54.5"},"reference-count":36,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,6,15]]},"DOI":"10.2169\/internalmedicine.2012-23","type":"journal-article","created":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T22:15:51Z","timestamp":1699827351000},"page":"1829-1835","source":"Crossref","is-referenced-by-count":3,"title":["Polypharmacy-related Shock Symptoms and Complications Associated with Phenothiazine"],"prefix":"10.2169","volume":"63","author":[{"given":"Shunsuke","family":"Nakamura","sequence":"first","affiliation":[{"name":"Department of General Internal Medicine, Kamigoto Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kamigoto Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kamigoto Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yamakawa","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kamigoto Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kamigoto Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamaki","family":"Ishima","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuka","family":"Kimura","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Aizawa","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Japan"},{"name":"Clinical Pharmacology Center, Jichi Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Thomas D, Wu K, Kath\u00f6fer S, et al. The antipsychotic drug chlorpromazine inhibits HERG potassium channels. Br J Pharmacol 139: 567-574, 2003.","DOI":"10.1038\/sj.bjp.0705283"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hals PA, Hall H, Dahl SG. Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites. Life Sci 43: 405-412, 1988.","DOI":"10.1016\/0024-3205(88)90519-X"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hals PA, Hall H, Dahl SG. Phenothiazine drug metabolites: dopamine D2 receptor, \u03b1<sub>1<\/sub>- and \u03b1<sub>2<\/sub>-adrenoceptor binding. Eur J Pharmacol 125: 373-381, 1986.","DOI":"10.1016\/0014-2999(86)90793-4"},{"key":"4","unstructured":"4. Barry D, Meyskens FL, Becker CE. Phenothiazine poisoning. A review of 48 cases. Calif Med 118: 1-5, 1973."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Dovjak P. Polypharmacy in elderly people. Wien Med Wochenschr 172: 109-113, 2022.","DOI":"10.1007\/s10354-021-00903-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Musch W, Hedeshi A, Decaux G. Low sodium excretion in SIADH patients with low diuresis. Nephron Physiol 96: p11-p18, 2004.","DOI":"10.1159\/000075575"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Haddad PM, Anderson IM. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 62: 1649-1671, 2002.","DOI":"10.2165\/00003495-200262110-00006"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Dougherty MM, Marraffa JM. Phenothiazines. In: Encyclopedia of Toxicology. 3ed ed. Wexler P, Ed. Academic Press, Oxford, 2014: 881-883.","DOI":"10.1016\/B978-0-12-386454-3.00769-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Higuchi H, Yabuki A, Ishii-Maruhama M, Tomoyasu Y, Maeda S, Miyawaki T. Hemodynamic changes by drug interaction of adrenaline with chlorpromazine. Anesth Prog 61: 150-154, 2014.","DOI":"10.2344\/0003-3006-61.4.150"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Cai HL, Deng Y, Fang PF, et al. A sensitive LC-MS\/MS method for analysis of pericyazine in presence of 7-hydroxypericyazine and pericyazine sulphoxide in human plasma and its application to a comparative bioequivalence study in Chinese healthy volunteers. J Pharm Biomed Anal 135: 67-74, 2017.","DOI":"10.1016\/j.jpba.2016.12.007"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hollister LE. Human pharmacology of antipsychotic and antidepressant drugs. Annu Rev Pharmacol 8: 491-516, 1968.","DOI":"10.1146\/annurev.pa.08.040168.002423"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kolecki P, Shih RD. Chapter 136 - Adverse effects of anticonvulsants and psychotropic agents. In: Pediatric Emergency Medicine. Baren JM, Rothrock SG, Brennan JA, Brown L, Eds. W.B. Saunders, Philadelphia, 2008: 970-974.","DOI":"10.1016\/B978-141600087-7.50139-2"},{"key":"13","unstructured":"13. Shin JG, Soukhova N, Flockhart DA. Effect of antipsychotic drugs on human liver cytochrome P-450 (CYP) isoforms in vitro: preferential inhibition of CYP2D6. Drug Metab Dispos 27: 1078-1084, 1999."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tateishi T, Kumai T, Watanabe M, Tanaka M, Kobayashi S. A comparison of the effect of five phenothiazines on hepatic CYP isoenzymes in rats. Pharmacol Toxicol 85: 252-256, 1999.","DOI":"10.1111\/j.1600-0773.1999.tb02018.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. de Witte P. Metabolism and pharmacokinetics of anthranoids. Pharmacology 47: 86-97, 1993.","DOI":"10.1159\/000139847"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Li F, Chin C, Wangsa J, Ho J. Excretion and metabolism of milnacipran in humans after oral administration of milnacipran hydrochloride. Drug Metab Dispos 40: 1723-1735, 2012.","DOI":"10.1124\/dmd.112.045120"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Thorn CF, Leckband SG, Kelsoe J, et al. PharmGKB summary: carbamazepine pathway. Pharmacogenet Genomics 21: 906-910, 2011.","DOI":"10.1097\/FPC.0b013e328348c6f2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Choi JS, Choi I, Choi DH. Effects of nifedipine on the pharmacokinetics of repaglinide in rats: possible role of CYP3A4 and P-glycoprotein inhibition by nifedipine. Pharmacol Rep 65: 1422-1430, 2013.","DOI":"10.1016\/S1734-1140(13)71502-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Seree EJ, Pisano PJ, Placidi M, Rahmani R, Barra YA. Identification of the human and animal hepatic cytochromes P450 involved in clonazepam metabolism. Fundam Clin Pharmacol 7: 69-75, 1993.","DOI":"10.1111\/j.1472-8206.1993.tb00219.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kuehl GE, Bigler J, Potter JD, Lampe JW. Glucuronidation of the aspirin metabolite salicylic acid by expressed UDP-glucuronosyltransferases and human liver microsomes. Drug Metab Dispos 34: 199-202, 2006.","DOI":"10.1124\/dmd.105.005652"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Humphries TJ. Famotidine: a notable lack of drug interactions. Scand J Gastroenterol Suppl 134: 55-60, 1987.","DOI":"10.3109\/00365528709090142"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hatanaka T. Clinical pharmacokinetics of pravastatin: mechanisms of pharmacokinetic events. Clin Pharmacokinet 39: 397-412, 2000.","DOI":"10.2165\/00003088-200039060-00002"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Oda M, Kotegawa T, Tsutsumi K, Ohtani Y, Kuwatani K, Nakano S. The effect of itraconazole on the pharmacokinetics and pharmacodynamics of bromazepam in healthy volunteers. Eur J Clin Pharmacol 59: 615-619, 2003.","DOI":"10.1007\/s00228-003-0681-4"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Nakashima A, Kawashita H, Masuda N, et al. Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes. Xenobiotica 35: 589-602, 2005.","DOI":"10.1080\/00498250500158175"},{"key":"#cr-split#-25.1","unstructured":"25. Peeters RP, Visser TJ. Metabolism of thyroid hormone. 2017. In: Endotext [Internet]. Feingold KR, Anawalt B, Boyce A, et al., Eds. MDText.com, Inc., South Dartmouth, [updated 2017 Jan 1"},{"key":"#cr-split#-25.2","unstructured":"cited 2023 Mar 23]. Available from: www.ncbi.nlm.nih.gov\/books\/NBK285545\/"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Thorn CF, Whirl-Carrillo M, Leeder JS, Klein TE, Altman RB. PharmGKB summary: phenytoin pathway. Pharmacogenet Genomics 22: 466-470, 2012.","DOI":"10.1097\/FPC.0b013e32834aeedb"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kudo S, Ishizaki T. Pharmacokinetics of haloperidol: an update. Clin Pharmacokinet 37: 435-456, 1999.","DOI":"10.2165\/00003088-199937060-00001"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Horikiri Y, Suzuki T, Mizobe M. Pharmacokinetics and metabolism of bisoprolol enantiomers in humans. J Pharm Sci 87: 289-294, 1998.","DOI":"10.1021\/js970316d"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Porras AG, Holland SD, Gertz BJ. Pharmacokinetics of alendronate. Clin Pharmacokinet 36: 315-328, 1999.","DOI":"10.2165\/00003088-199936050-00002"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Mori H, Tack J, Suzuki H. Magnesium oxide in constipation. Nutrients 13: 421, 2021.","DOI":"10.3390\/nu13020421"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Besag FMC, Berry D. Interactions between antiepileptic and antipsychotic drugs. Drug Saf 29: 95-118, 2006.","DOI":"10.2165\/00002018-200629020-00001"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Zackrisson AL, Holmgren P, Gladh AB, Ahlner J, Lindblom B. Fatal intoxication cases: cytochrome <i>P<\/i> <sub>450<\/sub> 2D6 and 2C19 genotype distributions. Eur J Clin Pharmacol 60: 547-552, 2004.","DOI":"10.1007\/s00228-004-0800-x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Dear JW. Chapter 40 - Poisoning. In: Clinical Biochemistry: Metabolic and Clinical Aspects. 3rd ed. Marshall WJ, Lapsley M, Day AP, Ayling RM, Eds. Churchill Livingstone, London, 2014: 787-807.","DOI":"10.1016\/B978-0-7020-5140-1.00040-7"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Vorvolakos T, Arseniou S, Samakouri M. There is no safe threshold for lead exposure: \u03b1 literature review. Psychiatriki 27: 204-214, 2016.","DOI":"10.22365\/jpsych.2016.273.204"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf 7: 11-22, 2016.","DOI":"10.1177\/2042098615615472"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/12\/63_2012-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T03:29:25Z","timestamp":1718422165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/12\/63_2012-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2012-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,15]]},"article-number":"2012-23"}}